Gastroenterology

Gastroenterology

Volume 111, Issue 2, August 1996, Pages 455-461
Gastroenterology

Clonal analysis of precancerous lesion of hepatocellular carcinoma

https://doi.org/10.1053/gast.1996.v111.pm8690212Get rights and content

Abstract

BACKGROUND & AIMS: It remains to be established whether precancerous lesion (dysplastic nodule) of hepatocellular carcinoma (HCC) is a neoplastic or hyperplastic lesion. Clonal analysis of this lesion was conducted to elucidate this important issue on histogenesis. METHODS: The method for clonal analysis was based on restriction fragment length polymorphism of the X chromosome-linked phosphoglycerokinase gene and on random inactivation of the gene by methylation. Clonal somatic mutations were also analyzed by DNA fingerprinting with two multilocus probes (33.6 and 33.15), and loss of heterozygosity was studied using five single-locus probes (MS1[1p33-p35], MS31[7p22-pter], MS43a[12q24.3- qter], MS8[5q35-qter], and g3[7q36-qter]). RESULTS: Clonal analysis by the phosphoglycerokinase gene-based method showed that all of the five dysplastic nodules and seven HCCs were monoclonal in origin. DNA fingerprinting showed clonal somatic mutations in six of 10 dysplastic nodules and in six of nine HCCs. Loss of heterozygosity was found in one dysplastic nodule (7p22-pter) and two HCCs (1p33-p35 and 12q24.3- qter). CONCLUSIONS: These results confirm monoclonality of HCC and show that hepatic precancerous lesion (dysplastic nodule) is not a hyperplastic but a neoplastic lesion, consisting of monoclonal cells with genetic alterations. (Gastroenterology 1996 Aug;111(2):455-61)

References (0)

Cited by (74)

  • Scheuer’s Liver Biopsy Interpretation

    2015, Scheuer's Liver Biopsy Interpretation
  • Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits

    2014, Journal of Hepatology
    Citation Excerpt :

    Depending on the degree of dysplasia, they are divided into low (LGDN) and high grade (HGDN). However, diagnosis of pre-malignant lesions and discrimination from eHCC is often difficult, and, although dysplastic nodules are considered monoclonal in origin, a clear probability of malignant transformation could not be attributed to a specific pre-neoplastic lesion [3]. According to current clinical guidelines, advanced HCCs are diagnosed with the use of a single dynamic imaging technique with biopsies being optional and most often reserved for ambiguous cases [4].

  • SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma

    2013, Journal of Hepatology
    Citation Excerpt :

    HCC occurs mainly in patients with chronic liver diseases such as hepatitis B virus (HBV) or hepatitis C virus infection-based liver cirrhosis. Dysplastic nodules (DNs) are precancerous lesions of HCC and high-grade DNs (HGDNs) have a high risk of malignant transformation [2–5]. However, detection of DNs, especially HGDNs, and correct differentiation from well-differentiated small HCC (WD-sHCC), are sometimes difficult on the basis of clinical, imaging, and even morphological examination.

  • Liver

    2009, Modern Surgical Pathology
  • Liver

    2009, Modern Surgical Pathology
View all citing articles on Scopus
View full text